Strong indications of serious and potentially fatal side effects? Columnists Commentary From the Editor Letters. In a recently published cross-sectional analysis, Mepham et al. Author information Copyright and License information Disclaimer. Low dose testosterone and Lupron. Male pattern hair loss also can occur over time as a result of androgenic interaction with pilosebaceous units in the skin
Endocr Pract ;
Hormone therapy for transgender patients
The primary pharmacological effect of Lupron administration is a decrease in the concentrations of testosterone and estradiol throughout the body. They will have to live in a kind of in between life with all of the health consequences that come with the use of artificial hormones. Management of female-to-male transgender persons: However, alkaline phosphatase, potassium, and creatinine levels were similar to male reference levels. Route Formulation Dosing Oral Estradiol 2—4 mg daily Parental subcutaneous, intramuscular Estradiol valerate 5—30 mg every 2 weeks Transdermal Estradiol 0. Theoretically, a teen could always desist from taking blockers and then normal puberty would ensue, although there is very little data in this area. World Professional Association for Transgender Health.
In most female-to-male patients unless testosterone is administered during the peri-pubertal periodthere is some degree of feminization that has taken place that cannot be reversed with exogenous testosterone. However, in some situations when delay of therapy may lead to psychologic and cognitive trauma in a child, it may be appropriate to commence therapy earlier In physical terms, this means that the pituitary, in an effort to restore normal functioning, will cull the number of GnRH receptors. LH stimulates the Leydig cells in the testes and the theca cells in the ovaries to produce testosterone Just take a look. Does anyone know about the effects of low-dose testosterone while on lupron? Hormone therapy has been shown to be associated with positive outcomes for patients, but there are important metabolic implications of therapy that must be carefully considered when treating patients.